definiens: in the foregoing sentence shall mean that [COMPANY] ( and its Affiliates and Sublicensees ) have com letel abandoned all efforts towards the Clinical Development of the Product and at least six ( 6 ) consecutive months have elapsed since the last Clinical Development - related activity undertaken by or on behalf of Co Therix ( or an Affiliate or Sublicensee ) without amending the Development Plan by the approval of the Joint Technical Committee ; provided that, for the avoidance of doubt, suspension of all Clinical Trials or the absence of Clinical Trials at a given time shall not constitute ( i.e., will not mean [COMPANY] Clinical Development hereunder ) so long as [COMPANY] ( or an Afijliate or Sublicensee ) is using Commercially Reasonable Efforts to move Development efforts forward or obtain Regulatory Approval . For so long as at least one Product remains in Development ( Le